Table 2

Relations of baseline clinical variables to mortality after first-ever stroke

All stroke/TIA (n=155), 84 died during follow-upBrain infarction (n=97), 53 died during follow-up
Adjusted for age at baseline models AAdjusted for age at baseline models A
Systolic blood pressure (mm Hg)1.00 (0.99 to 1.02)1.00 (0.98 to 1.01)
p=0.418p=0.730
S-total cholesterol (mmol/l)0.85 (0.69 to 1.04)0.88 (0.66 to 1.17)
p=0.122p=0.384
Atrial fibrillation1.14 (0.56 to 2.29)0.54 (0.20 to 1.43)
p=0.722p=0.216
ECG-LVH1.88 (1.04 to 3.39)2.54 (1.25 to 5.15)
p=0.035p=0.010
Hypertension prevalence1.19 (0.64 to 2.20)1.66 (0.74 to 3.71)
p=0.576p=0.217
Diabetes prevalence1.67 (1.04 to 2.69)1.85 (1.00 to 3.41)
p=0.035p=0.050
Treatment with antihypertensives1.56 (1.02 to 2.40)2.60 (1.50 to 4.50)
p=0.042p=0.001
Treatment with antidiabetics1.28 (0.71 to 2.39)1.48 (0.58 to 3.77)
p=0.514p=0.410
Treatment with lipid-lowering medicine1.53 (0.83 to 2.84)2.17 (1.01 to 4.65)
p=0.173p=0.046
Current cigarette smoking0.97 (0.56 to 1.69)1.05 (0.54 to 2.04)
p=0.921p=0.885
  • Data are presented as Cox proportional HRs (95% CI) for a 1SD increase in the continuous variables or transfer from one level to another of the dichotomous variables.

  • LVH, left ventricular hypertrophy; S, serum; TIA, transient ischaemic attack.